ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
ResMed (NYSE: RMD, ASX: RMD) has announced plans to release its second quarter fiscal 2025 financial and operational results on Thursday, January 30, 2025, after the New York Stock Exchange market close. The company will follow the release with a management-hosted webcast to discuss the quarterly results.
ResMed (NYSE: RMD, ASX: RMD) ha annunciato piani per rilasciare i suoi risultati finanziari e operativi del secondo trimestre dell'esercizio 2025 il giovedì 30 gennaio 2025, dopo la chiusura del mercato della Borsa di New York. L'azienda seguirà il rilascio con un webcast ospitato dalla direzione per discutere i risultati trimestrali.
ResMed (NYSE: RMD, ASX: RMD) ha anunciado planes para publicar sus resultados financieros y operativos del segundo trimestre del año fiscal 2025 el jueves 30 de enero de 2025, después del cierre del mercado de la Bolsa de Nueva York. La compañía seguirá la publicación con un webcast organizado por la dirección para discutir los resultados trimestrales.
ResMed (NYSE: RMD, ASX: RMD)는 2025 회계연도 2분기 재무 및 운영 결과를 2025년 1월 30일 목요일에 뉴욕 증권 거래소 시장 마감 후 발표할 계획이라고 발표했습니다. 회사는 분기 결과를 논의하기 위해 경영진 주최의 웹캐스트를 진행할 것입니다.
ResMed (NYSE: RMD, ASX: RMD) a annoncé des plans pour publier ses résultats financiers et opérationnels du deuxième trimestre de l'exercice 2025 le jeudi 30 janvier 2025, après la fermeture du marché de la Bourse de New York. L'entreprise suivra la publication d'un webinaire animé par la direction pour discuter des résultats trimestriels.
ResMed (NYSE: RMD, ASX: RMD) hat Pläne bekannt gegeben, seine finanziellen und operativen Ergebnisse für das zweite Quartal des Geschäftsjahres 2025 am Donnerstag, den 30. Januar 2025, nach Schluss der New Yorker Börse zu veröffentlichen. Das Unternehmen wird der Veröffentlichung einen von der Geschäftsführung gehosteten Webcast folgen lassen, um die Quartalsergebnisse zu besprechen.
- None.
- None.
SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| • Location: | https://investor.resmed.com |
| • Date: | Thursday, January 30, 2025 |
| • Time: | 1:30 p.m. PST / 4:30 p.m. EST |
| • International: | London, Thursday, January 30, 2025, 9:30 p.m. GMT |
| Sydney, Friday, January 31, 2025, 8:30 a.m. AEDT | |
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from January 30, 2025, until February 13, 2025, at:
| • U.S.: +1 877.660.6853 |
| • International: +1 201.612.7415 |
| • Conference ID: 13750689 |
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors +1 858.836.5000 investorrelations@resmed.com | For media +1 619.510.1281 news@resmed.com |
FAQ
When will ResMed (RMD) release its Q2 2025 earnings?
How can investors access RMD's Q2 2025 earnings results?
What fiscal period will RMD's upcoming earnings report cover?
Will RMD management hold an earnings call for Q2 2025 results?
